Updates for c.1420G>A:
2023-06-01 class updated from VUS4 to disease-causing, varying clinical consequence




Variant NM_000492.4:c.1420G>A


Variant details:
Name NM_000492.4:c.1420G>A
Protein name NP_000483.3:p.(Glu474Lys)
Genomic name (hg19)     chr7:g.117199545G>A    UCSC    
Genomic name (hg38) chr7:g.117559491G>A    UCSC
#Exon/intron exon 11
Legacy Name E474K
Class disease-causing
Subclass varying clinical consequence
WT sequence TTCACTTCTAATGGTGATTATGGGA G AACTGGAGCCTTCAGAGGGTAAAAT
Mutant sequence TTCACTTCTAATGGTGATTATGGGA A AACTGGAGCCTTCAGAGGGTAAAAT

Other databases:
dbSNP
rs756206533



Pathogenicity predictors:



Response to modulators:


Modulator FDA approval EMA approval in vitro / ex vivo data clinical data
IVAnononono
TEZ-IVAnononono
ELX-TEZ-IVA yesnoyesno
VNZ-TEZ-DIVA yesnoyesno

clinical and functional data presented above are provided by Vertex


No patient found in CFTR-NGS catalogue


4 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 4
CF 2
CFTR-RD2
  • Bronchiectasis  1
  • CBAVD  1




Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing

Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
Bronchiectasis 5849heterozygoteCF-causing - Trans
CF 6516heterozygoteCF-causing- Undef
CF 2880heterozygoteCF-causing- Undef
CBAVD 6390heterozygoteCFTR-RD-causing- Undef


Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing



            CFTR variants are clustered into five groups (click here for more details about the classification of variants):
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.



Go to CFTRare